Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Female pulmonary arterial hypertension is associated with decreased microRNA96 expression

Emma Wallace, Kirsty Mair, Lu Long, Xu D. Yang, Nick Morrell, Andrew H. Baker, Margaret R. MacLean
European Respiratory Journal 2014 44: P2364; DOI:
Emma Wallace
1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsty Mair
1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu Long
2School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xu D. Yang
2School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nick Morrell
2School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew H. Baker
1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret R. MacLean
1Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction Mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene underlie heritable PAH. PAH occurs more frequently in women. MicroRNAs (miRs) are gene regulators involved in vascular processes including proliferation.

Aims We investigated miR expression in mice with a BMPR2 R899X mutation.

Methods miRNA and mRNA expression by qRTPCR and protein by westerns were determined in human pulmonary arterial smooth muscle cells (hPASMCs). Proliferation was assessed by cell counts. In vivo levels of oestrogen were depleted in female mice using the aromatase inhibitor anastrozole (3mg/kg/day for 2 weeks). All data, n>6.

Results Expression of miR96 was decreased from 1±0.09 to 0.09±0.002 (p<0.001) in female BMPR2 R899X mice PASMCs vs. female wild type (WT), not male. miR96 targets the gene for 5HT1B receptor and both 5HT1B mRNA (4.82±1.47 vs. 1.00±0.67, p<0.05) and protein (0.644±0.14 vs. 0.274±0.03, p<0.05) were increased in the female (not male) BMPR2 R899X vs. WT PASMCs. miR96 expression was decreased by ∼82% and 5HT1B protein elevated by ∼61% in PASMCs from female PAH patients (not males) vs. Controls and associated with increased serotonin-induced proliferation. Pre-miR-96 transfected in human PASMCs decreased 5HT1B protein expression by 40%. Depletion of oestrogen caused a ∼77% increased expression of miR96 and an ∼84% decrease in 5HT1B expression in whole lung. In hPASMCs, 1nM oestrogen decreased miR96 expression by ∼80% and increased 5HT1B expression 2-fold.

Conclusions Oestrogen-induced decreased miR96 expression, leading to derepressed 5HT1B expression may predispose female PASMCs to proliferation, contributing to the development of PAH.

  • Pulmonary hypertension
  • Pharmacology
  • Experimental approaches
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Emma Wallace, Kirsty Mair, Lu Long, Xu D. Yang, Nick Morrell, Andrew H. Baker, Margaret R. MacLean
European Respiratory Journal Sep 2014, 44 (Suppl 58) P2364;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Emma Wallace, Kirsty Mair, Lu Long, Xu D. Yang, Nick Morrell, Andrew H. Baker, Margaret R. MacLean
European Respiratory Journal Sep 2014, 44 (Suppl 58) P2364;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Tryptophan hydroxylase-1 inhibitors reduce serotonin levels and mast cell numbers in monocrotaline-treated rat lungs
  • Caspase inhibition stabilizes progressive vascular remodeling in established pulmonary hypertension
  • Effects of apoptosis signal- regulating kinase 1 (ASK1) inhibition in experimental pressure overload-induced right ventricular dysfunction
Show more 4.3 Pulmonary Circulation and Pulmonary Vascular Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society